Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Certepetide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lisata Signs Research Agreement on Certepetide for Endometriosis
    Lisata Signs Research Agreement on Certepetide for Endometriosis

    28 Oct 2024

    // #N/A

    https://www.globenewswire.com/news-release/2024/10/28/2970055/18623/en/Lisata-Therapeutics-Announces-Sponsored-Preclinical-Research-Agreement-with-the-University-of-Cincinnati-to-Study-Certepetide-for-the-Treatment-of-Endometriosis.html

    #N/A
    28 Oct 2024
    Share Share
    Lisata Therapeutics To Report Q2 2024 Results On August 12
    Lisata Therapeutics To Report Q2 2024 Results On August 12

    05 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/05/2924224/18623/en/Lisata-Therapeutics-to-Report-Second-Quarter-2024-Financial-Results-and-Provide-a-Business-Update-on-Monday-August-12-2024.html

    GLOBENEWSWIRE
    05 Aug 2024
    Share Share
    Lisata's Certepetide Shows Promise For Intrahepatic Cholangiocarcinoma
    Lisata's Certepetide Shows Promise For Intrahepatic Cholangiocarcinoma

    10 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/10/2911056/18623/en/Lisata-Therapeutics-Certepetide-Shows-Promise-in-Improving-Standard-Treatment-for-Intrahepatic-Cholangiocarcinoma-in-a-Preclinical-Model.html

    GLOBENEWSWIRE
    10 Jul 2024
    Share Share
    Lisata Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial
    Lisata Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial

    13 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/13/2898249/18623/en/Lisata-Therapeutics-Announces-Full-Enrollment-of-Pancreatic-Cancer-Cohort-of-CENDIFOX-Trial.html

    GLOBENEWSWIRE
    13 Jun 2024
    Share Share
    Lisata Receives EMA Paediatric Waiver For Certepetide In Pancreatic Cancer
    Lisata Receives EMA Paediatric Waiver For Certepetide In Pancreatic Cancer

    20 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/20/2884845/18623/en/Lisata-Therapeutics-Receives-Paediatric-Investigation-Plan-Waiver-from-the-European-Medicines-Agency-for-Certepetide-in-Pancreatic-Cancer.html

    GLOBENEWSWIRE
    20 May 2024
    Share Share